Arbutus Biopharma | Investor Presentation Deck

Slide schematic 6/6

diagram 1/1 image 2/2 paragraph 2/2 title 1/1

Components 6

timeline logo logo paragraph paragraph headline

Tools 1

The slide presents a clinical trial with Attention (primary objective: evaluate safety and reactogenicity), Interest (POC Phase 2a clinical trial evaluating imdusiran), Desire (imdusiran in combination with Vaccitech's immunotherapeutic, VTP-300), and Action (trial design timeline showing two arms, randomization, and follow-up periods).

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

gantt-chart 80%

The slide uses a timeline-based visual to represent clinical trial phases and patient cohorts.

Find anything

Shows two parallel trial arms with timelines and patient counts.